American-Chinese Medical Exchange Tackles Hep. D, Autism, AI in Medicine

Over a hundred healthcare workers joined the American-Chinese Medical Exchange Society’s annual meeting at the Sherman Auditorium in Beth Israel Deaconess Medical Center on Sept. 14.

Faculty and leaders from several area hospitals and teaching schools, including Harvard Medical School, Massachusetts General Hospital, Beth Israel, and Boston Children’s Hospital attended with counterparts from Shanghai General Hospital and Zhejiang University. The group discussed “frontiers and future directions in medicine” at the meeting titled, “Medical Advances 2025.”

American Chinese Medical Exchange Society’s President Dr. Xue-Jun Kong of Harvard Medical School (see profile on page 3) gave an opening message, affirming the group’s goals of uniting clinicians, advancing medical education and care quality globally.

Artificial intelligence and precision medicine as well as cross-disciplinary collaboration were touted as “core drivers” of the next era of healthcare globally.

In addition, the risks and prevalence of Hepatitis D, a liver disease, were discussed by Dr. Daryl Lau of Beth Israel; anti-obesity therapeutics in practice was discussed by Dr. Zhao Liu of Beth Israel; and cancer immunotherapy was discussed by Dr. Min Le of Brigham and Women’s Hospital.

Other topics included the transformation of China’s public hospitals by Dr. Jun Liu of Shanghai General Hospital and the relationship between the gut and brain for people with autism by Dr. Xue-Jun Kong and Chongzhao Ran.

“Everything we do is to move medicine forward and bring hope to more patients,” said Dr. Kong.

­

— Staff report